TY - JOUR
T1 - Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference
T2 - Bridging the Gap 2015, Beijing, China
AU - Lu, Jin
AU - Hou, Jian
AU - Liu, Kai Yan
AU - Parmar, Simrit
AU - De La Fuente, Adolfo
AU - Andersson, Börje
AU - Yan, ChenHua
AU - Zhou, Daobin
AU - Tan, Daryl
AU - Ritchie, David
AU - Wu, Deipei
AU - Shpall, Elizabeth
AU - Laport, Ginna G.
AU - Li, JianYong
AU - Hu, Jiong
AU - Zhang, Lian Sheng
AU - Wang, Michael
AU - Malhotra, Pankaj
AU - Jiang, Qian
AU - Qin, Yazhen
AU - Wong, Raymond
AU - Champlin, Richard
AU - Issaragrisil, Surapol
AU - Iyer, Swaminathan
AU - Mathews, Vikram
AU - Wang, Y.
AU - Hu, Y.
AU - Xiao, Zhijian
AU - Shao, Zonghong
AU - Rosengarten, Rafael
AU - Steuernagle, Jon
AU - Xiao, Jun Huang
AU - Orlowski, Robert
AU - Chim, James Chor Sang
PY - 2016/7/2
Y1 - 2016/7/2
N2 - Abstract: The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.
AB - Abstract: The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.
KW - APHCON
KW - China
KW - MDRing
KW - Myeloma
KW - survey
UR - http://www.scopus.com/inward/record.url?scp=84958775269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958775269&partnerID=8YFLogxK
U2 - 10.3109/10428194.2015.1135434
DO - 10.3109/10428194.2015.1135434
M3 - Letter
C2 - 26887657
AN - SCOPUS:84958775269
VL - 57
SP - 1534
EP - 1538
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 7
ER -